SFS
ZSPH

Summit Financial Strategies’s ZS PHARMA INC COMS TK (DE) ZSPH Stock Holding History

Summit Financial Strategies’s Portfolio ZSPH Stock Details ZSPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-7,357
Closed -$306K – 44
2014
Q4 		$306K Buy
+7,357
New +$290K 0.25% 29

Other funds holding ZSPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DPA
Devon Park Associates $30.8M AUM 0.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Summit Financial Strategies's ZSPH Position: Q1 2015 in Review

Summit Financial Strategies sold out of ZS PHARMA INC COMS TK (DE) (ZSPH) in Q1 2015, closing a stake of 7,357 shares — an estimated $306K sold.

Summit Financial Strategies first reported a position in ZSPH in Q4 2014 and held it in 1 quarter. The position peaked at $306K in Q4 2014. 92 funds tracked by Wall St. Rank hold ZSPH as of Q1 2015.

  • Summit Financial Strategies reported no remaining ZS PHARMA INC COMS TK (DE) position as of Q1 2015 after selling out during the quarter.
  • Summit Financial Strategies sold 7,357 ZS PHARMA INC COMS TK (DE) shares in Q1 2015, an estimated $306K.
  • Summit Financial Strategies first reported a position in ZS PHARMA INC COMS TK (DE) in Q4 2014 and held it in 1 quarter.
  • Summit Financial Strategies's ZS PHARMA INC COMS TK (DE) position peaked at $306K in Q4 2014.
  • 92 funds tracked by Wall St. Rank held ZS PHARMA INC COMS TK (DE) as of Q1 2015.

Based on Summit Financial Strategies's 13F filing for Q1 2015, filed 14 May 2015.